The effect of Iranian medicine drug on increasing visual response to auditory stimuli in children with autism spectrum disorders

The effect of Iranian medicine drug on increasing visual response to auditory stimuli in children with autism spectrum disorders; Double-blind clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220628055306N1

Enrollment

Registered

2022-08-31

Start date

2022-08-23

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment of autism with traditional medicine products. Childhood autism

Interventions

Intervention 1: Intervention group: 3 to 5 year old children with autism spectrum disorder who are prescribed 5 cc of traditional medicine product three times a day for 8 weeks, which is a combination

Eligibility

Sex/Gender

All

Age

3 Years to 5 Years

Inclusion criteria

Inclusion criteria: Having autism Parental consent

Exclusion criteria

Exclusion criteria: taking medication

Design outcomes

Primary

Measure	Time frame
Measuring the rate of visual response to multiple auditory stimuli. Timepoint: The second week, the fourth week, the sixth week, the eighth week. Method of measurement: Record the visual response to the auditory stimulus.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Dayani

Arak University of Medical Sciences

najaf2@yahoo.com+98 86 3313 6055

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026